“Risk Behaviour And Time As Covariates For Efficacy Of The Hiv Vaccine Regimen Alvac-Hiv (Vcp1521) And Aidsvax B/e: A Post-Hoc Analysis Of The Thai Phase 3 Efficacy Trial Rv 144.”. Lancet Infect Dis 12 (7). Lancet Infect Dis: 531-7. doi:10.1016/S1473-3099(12)70088-9.
. 2012. “Safety And Reactogenicity Of Canarypox Alvac-Hiv (Vcp1521) And Hiv-1 Gp120 Aidsvax B/e Vaccination In An Efficacy Trial In Thailand.”. Plos One 6 (12). Plos One: e27837. doi:10.1371/journal.pone.0027837.
. 2011. “Vaccination With Alvac And Aidsvax To Prevent Hiv-1 Infection In Thailand.”. N Engl J Med 361 (23). N Engl J Med: 2209-20. doi:10.1056/NEJMoa0908492.
. 2009.